Evidence map›Paper›PMID 33733424›Full record

ArticleJournal of racial and ethnic health disparities2022

HIV Pre-exposure Prophylaxis Use and Persistence among Black Ciswomen: "Women Need to Protect Themselves, Period".

Maria Pyra, Amy K Johnson, Samantha Devlin, A Ziggy Uvin, Shemeka Irby, Eric Stewart, Cori Blum, Maya Green, Sadia Haider, Lisa R Hirschhorn and 1 more

Abstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria PyraHoward Brown Health, Chicago, IL, USA. mariap@howardbrown.org.ORCID 0000-0003-1783-0943
Amy K JohnsonAnn & Robert H. Luries Children's Hospital of Chicago, Chicago, IL, USA.
Samantha DevlinDepartment of Medicine, University of Chicago, Chicago, IL, USA.
A Ziggy UvinDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Shemeka IrbyDominican University, River Forest, IL, USA.
Eric StewartHoward Brown Health, Chicago, IL, USA.
Cori BlumHoward Brown Health, Chicago, IL, USA.
Maya GreenHoward Brown Health, Chicago, IL, USA.
Sadia HaiderDepartment of Obstetrics-Gynecology, University of Chicago, Chicago, IL, USA.
Lisa R HirschhornFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Jessica P RidgwayFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Funding

Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Michael E Newcomb · 2015 to 2026
$38.4M
NIAID NIH HHS P30 AI117943
6 · The paper itself

Abstract

backgroundDisparities in HIV incidence and PrEP use among Black ciswomen remain. We examine factors associated with PrEP persistence using mixed methods.

settingBlack ciswomen in Chicago, IL, prescribed PrEP at a federally qualified health center (FQHC).

methodsWe used electronic health data to determine PrEP persistence (Proportion of Days Covered ≥86% at 6 months) and tested demographic and clinical factors in logistic regressions. We interviewed eight Black ciswomen, purposefully selected by PrEP persistence.

resultsAmong 112 Black ciswomen, 18% were persistent. In adjusted models, neighborhood, visit reason (at initiation), and initiation year were significantly associated with persistence. Qualitatively, we found little evidence of cost or adherence as barriers; participants reported low community awareness, importance of providers, and concerns around stigma, side effects, and pregnancy while using PrEP.

conclusionWhile persistence among Black ciswomen was low, patients were often making decisions based on perceived HIV risk. We identified real-world barriers to address in future interventions.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisChicagoFemaleHomosexuality, MaleHumansLogistic ModelsAnti-HIV AgentsBlackCiswomenHIV PrEPMixed methods

Identifiers

PMID33733424
PMCPMC7968858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.